Key result
LVAD therapy impacts quality of life in end-stage heart failure across current research.
Why the study?
The impact of left ventricular assist devices on quality of life in patients with end-stage heart failure is not well defined.
LVAD destination therapy may affect quality of life in end-stage HF; leaves open need for prospective studies before changing practice.
As more patients have a diagnosis of end-stage heart failure, nurses are more likely to encounter the use of left ventricular assist devices (LVADs). Currently, LVADs are used as a bridge to cardiac transplantation. However, current research suggests that LVADs may be used as destination therapy for those unable to undergo cardiac transplantation. The technology has been developed to sustain life, but what is the impact of technology on the quality of life? This article reviews current research on the quality of life with an LVAD.
No takes yet. Share an insight, caveat, or question.
Laura S. Savage (2003) conducted a review in End-stage heart failure. Left ventricular assist devices (LVADs) was evaluated on Quality of life. This article reviews current research on the impact of left ventricular assist devices on the quality of life among patients with end-stage heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: